AU1189392A - Pharmaceutical agent - Google Patents
Pharmaceutical agentInfo
- Publication number
- AU1189392A AU1189392A AU11893/92A AU1189392A AU1189392A AU 1189392 A AU1189392 A AU 1189392A AU 11893/92 A AU11893/92 A AU 11893/92A AU 1189392 A AU1189392 A AU 1189392A AU 1189392 A AU1189392 A AU 1189392A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical agent
- pharmaceutical
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9102727 | 1991-02-08 | ||
| GB919102727A GB9102727D0 (en) | 1991-02-08 | 1991-02-08 | Pharmaceutical agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1189392A true AU1189392A (en) | 1992-09-07 |
Family
ID=10689748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU11893/92A Abandoned AU1189392A (en) | 1991-02-08 | 1992-02-05 | Pharmaceutical agent |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1064809A (en) |
| AP (1) | AP9200355A0 (en) |
| AU (1) | AU1189392A (en) |
| CA (1) | CA2060825A1 (en) |
| GB (2) | GB9102727D0 (en) |
| HU (1) | HUT60489A (en) |
| IE (1) | IE920243A1 (en) |
| IL (1) | IL100793A0 (en) |
| MX (1) | MX9200532A (en) |
| PT (1) | PT100097A (en) |
| WO (1) | WO1992013853A1 (en) |
| ZA (1) | ZA92729B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU656454B2 (en) * | 1992-02-14 | 1995-02-02 | E.R. Squibb & Sons, Inc. | Biphenyl-substituted quinoline derivatives |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| DK3311845T3 (en) | 2013-09-16 | 2020-04-06 | Astrazeneca Ab | THERAPEUTIC POLYMER NANOPARTICLES AND PROCEDURES FOR PREPARING AND USING THEREOF |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| BG92674A (en) * | 1989-08-11 | 1993-12-24 | David Roberts | METHOD FOR OBTAINING QUINOLINE DERIVATIVES |
-
1991
- 1991-02-08 GB GB919102727A patent/GB9102727D0/en active Pending
-
1992
- 1992-01-27 IE IE024392A patent/IE920243A1/en unknown
- 1992-01-28 IL IL100793A patent/IL100793A0/en unknown
- 1992-01-31 ZA ZA92729A patent/ZA92729B/en unknown
- 1992-02-03 AP APAP/P/1992/000355A patent/AP9200355A0/en unknown
- 1992-02-05 AU AU11893/92A patent/AU1189392A/en not_active Abandoned
- 1992-02-05 WO PCT/GB1992/000214 patent/WO1992013853A1/en active Application Filing
- 1992-02-05 HU HU9200354A patent/HUT60489A/en unknown
- 1992-02-05 GB GB9202377A patent/GB2252557A/en not_active Withdrawn
- 1992-02-06 PT PT100097A patent/PT100097A/en not_active Application Discontinuation
- 1992-02-07 MX MX9200532A patent/MX9200532A/en unknown
- 1992-02-07 CA CA002060825A patent/CA2060825A1/en not_active Abandoned
- 1992-02-08 CN CN92101425A patent/CN1064809A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU656454B2 (en) * | 1992-02-14 | 1995-02-02 | E.R. Squibb & Sons, Inc. | Biphenyl-substituted quinoline derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1064809A (en) | 1992-09-30 |
| CA2060825A1 (en) | 1992-08-09 |
| PT100097A (en) | 1993-04-30 |
| GB9102727D0 (en) | 1991-03-27 |
| GB9202377D0 (en) | 1992-03-18 |
| IL100793A0 (en) | 1992-09-06 |
| AP9200355A0 (en) | 1993-08-03 |
| HU9200354D0 (en) | 1992-04-28 |
| ZA92729B (en) | 1992-11-25 |
| HUT60489A (en) | 1992-09-28 |
| IE920243A1 (en) | 1992-08-12 |
| GB2252557A (en) | 1992-08-12 |
| MX9200532A (en) | 1992-08-01 |
| WO1992013853A1 (en) | 1992-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU656157B2 (en) | Pharmaceutical agents | |
| AU2087992A (en) | Pharmaceutical combination formulation | |
| PL304317A1 (en) | Pharmaceutical agent | |
| PL304508A1 (en) | Pharmaceutical agent | |
| AU3542993A (en) | Pharmaceutical compounds | |
| AU1189392A (en) | Pharmaceutical agent | |
| AU2392492A (en) | Pharmaceutical composition | |
| GB9311030D0 (en) | Pharmaceutical formulations | |
| GB9323399D0 (en) | Pharmaceutical formulations | |
| AU1500992A (en) | Pharmaceutical compound | |
| AU2493792A (en) | Pharmaceutical preparation | |
| AU2537992A (en) | Pharmaceutical compositions | |
| AU658903B2 (en) | Snake-controlling agent | |
| AU1740692A (en) | New medicinal use | |
| AU1103092A (en) | Immunopotentiating drug | |
| PL297548A1 (en) | Pharmaceutical agent | |
| AU7135091A (en) | Pharmaceutical composition | |
| AU3528593A (en) | Pharmaceutical composition | |
| GB9104124D0 (en) | Pharmaceutical agent | |
| GB9104123D0 (en) | Pharmaceutical agent | |
| AU8996291A (en) | Pharmaceutical formulations | |
| AU673835C (en) | Medicinal composition comprising TCF-II | |
| AU6933794A (en) | Pharmaceutical formulations | |
| GB9316253D0 (en) | Pharmaceutical formulation | |
| GB9315016D0 (en) | Pharmaceutical formulation |